Correani V - Search Results

1

Reversible redox modifications in the microglial proteome challenged by beta amyloid.

Correani V, Di Francesco L, Cera I, Mignogna G, Giorgi A, Mazzanti M, Fumagalli L, Fabrizi C, Maras B, Schininà ME. Correani V, et al. Mol Biosyst. 2015 Jun;11(6):1584-93. doi: 10.1039/c4mb00703d. Mol Biosyst. 2015. PMID: 25728364

2

14-3-3ε marks the amyloid-stimulated microglia long-term activation.

Di Francesco L, Correani V, Fabrizi C, Fumagalli L, Mazzanti M, Maras B, Schininà ME. Di Francesco L, et al. Among authors: correani v. Proteomics. 2012 Jan;12(1):124-34. doi: 10.1002/pmic.201100113. Epub 2011 Dec 9. Proteomics. 2012. PMID: 22065591

3

Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid.

Eufemi M, Cocchiola R, Romaniello D, Correani V, Di Francesco L, Fabrizi C, Maras B, Schininà ME. Eufemi M, et al. Among authors: correani v. Neurochem Int. 2015 Feb;81:48-56. doi: 10.1016/j.neuint.2015.01.007. Epub 2015 Jan 26. Neurochem Int. 2015. PMID: 25633229

4

Plasma Membrane Protein Profiling in Beta-Amyloid-Treated Microglia Cell Line.

Correani V, Di Francesco L, Mignogna G, Fabrizi C, Leone S, Giorgi A, Passeri A, Casata R, Fumagalli L, Maras B, Schininà ME. Correani V, et al. Proteomics. 2017 Sep;17(17-18). doi: 10.1002/pmic.201600439. Proteomics. 2017. PMID: 28815942

5

Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells.

Correani V, Martire S, Mignogna G, Caruso LB, Tempera I, Giorgi A, Grieco M, Mosca L, Schininà ME, Maras B, d'Erme M. Correani V, et al. Biochem Pharmacol. 2019 Sep;167:50-57. doi: 10.1016/j.bcp.2018.10.026. Epub 2018 Nov 9. Biochem Pharmacol. 2019. PMID: 30414941

6

Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.

Baiocchini A, Montaldo C, Conigliaro A, Grimaldi A, Correani V, Mura F, Ciccosanti F, Rotiroti N, Brenna A, Montalbano M, D'Offizi G, Capobianchi MR, Alessandro R, Piacentini M, Schininà ME, Maras B, Del Nonno F, Tripodi M, Mancone C. Baiocchini A, et al. Among authors: correani v. PLoS One. 2016 Mar 21;11(3):e0151736. doi: 10.1371/journal.pone.0151736. eCollection 2016. PLoS One. 2016. PMID: 26998606 Free PMC article.

7

PAR1 activation affects the neurotrophic properties of Schwann cells.

Pompili E, Fabrizi C, Somma F, Correani V, Maras B, Schininà ME, Ciraci V, Artico M, Fornai F, Fumagalli L. Pompili E, et al. Among authors: correani v. Mol Cell Neurosci. 2017 Mar;79:23-33. doi: 10.1016/j.mcn.2017.01.001. Epub 2017 Jan 4. Mol Cell Neurosci. 2017. PMID: 28064059

8

Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.

Martire S, Fuso A, Mosca L, Forte E, Correani V, Fontana M, Scarpa S, Maras B, d'Erme M. Martire S, et al. Among authors: correani v. J Alzheimers Dis. 2016 Aug 10;54(1):307-24. doi: 10.3233/JAD-151040. J Alzheimers Dis. 2016. PMID: 27567805

9

Variability in Probiotic Formulations Revealed by Proteomics and Physico-chemistry Approach in Relation to the Gut Permeability.

Razafindralambo H, Correani V, Fiorucci S, Mattei B. Razafindralambo H, et al. Among authors: correani v. Probiotics Antimicrob Proteins. 2020 Sep;12(3):1193-1202. doi: 10.1007/s12602-019-09590-1. Probiotics Antimicrob Proteins. 2020. PMID: 31482402

10

A Combined Proteomics, Metabolomics and In Vivo Analysis Approach for the Characterization of Probiotics in Large-Scale Production.

Bianchi L, Laghi L, Correani V, Schifano E, Landi C, Uccelletti D, Mattei B. Bianchi L, et al. Among authors: correani v. Biomolecules. 2020 Jan 18;10(1):157. doi: 10.3390/biom10010157. Biomolecules. 2020. PMID: 31963736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page